Patent ID: 8580256
Filing Date: 2013-11-12
Classification: A61K,A61P,C07K

Abstract:
1. An antibody formulation comprising: a) at least 10 mg/ml of one or more antibodies or fragments thereof that specifically bind to an HBV antigen wherein at least one of said antibodies or antibody fragments comprises a variable light (VL) domain having the amino acid sequence of SEQ ID NO. 1 and a variable heavy (VH) domain having the amino acid sequence of SEQ ID NO. 2; and at least a second of said antibodies or antibody fragments comprises a variable light (VL) domain having the amino acid sequence of SEQ ID NO. 3 and a variable heavy (VH) domain having the amino acid sequence of SEQ ID NO. 4; b) alanine at a concentration of 90 mM; c) sodium citrate at a concentration of 20 mM; d) polysorbate 80 at a concentration of 0.1%; and e) trehalose at a concentration of 3%.